N4 Pharma Plc (AIM:N4P)

Market Cap	2.15M
Revenue (ttm)	5.86K
Net Income (ttm)	-1.08M
Shares Out	537.56M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	676,183
Average Volume	2,059,410
Open	0.4000
Previous Close	0.4000
Day's Range	0.3500 - 0.4000
52-Week Range	0.3500 - 0.9000
Beta	0.66
RSI	37.85
Earnings Date	Jun 24, 2025

About N4 Pharma

N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery systems to enhance the cellular delivery of cancer treatments, gene therapy, and vaccines in the United Kingdom. It develops Nuvec, which offers silica nanoparticles with irregular surface structure and polyethyleneimine that traps and protects nucleic acid; and Liptide, a platform to deliver a proprietary siRNA sequence to silence a fibrotic gene for the treatment of glaucoma. The company was incorporated in 1979 and is based in London, the United Kingdom...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1979
• Employees: 5
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: N4P